title: Is ICGA still relevant in inflammatory eye disorders? Why this question has to be dealt with separately from other eye conditions.
authors.forename: Carl P
authors.initials: CP
authors.lastname: Herbort
authors.forename: Piergiorgio
authors.initials: P
authors.lastname: Neri
authors.forename: Ahmed A
authors.initials: AA
authors.lastname: El Asrar
authors.forename: Vishali
authors.initials: V
authors.lastname: Gupta
authors.forename: Philippe
authors.initials: P
authors.lastname: Kestelyn
authors.forename: Moncef
authors.initials: M
authors.lastname: Khairallah
authors.forename: Alessandro
authors.initials: A
authors.lastname: Mantovani
authors.forename: Ilknur
authors.initials: I
authors.lastname: Tugal-Tutkun
authors.forename: Marina
authors.initials: M
authors.lastname: Papadia
mesh_terms: D004396:Coloring Agents / Q000737:chemistry; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green / Q000737:chemistry; D015866:Uveitis, Posterior / Q000175:diagnosis*
chemical_list: D004396:Coloring Agents; D007208:Indocyanine Green